Literature DB >> 4353819

Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages.

R Keller.   

Abstract

Syngeneic tumor cell lines induced in inbred DA rats by polyoma virus, dimethylbenzanthracene, or methylcholanthrene were interacted in vitro with syngeneic effector cells. Glycogen-induced peritoneal exudate cells, predominantly polymorphonuclear leukocytes, and proteose peptone-induced peritoneal cells, principally macrophages, were the effector cells employed. Activated, nonimmune macrophages or exudative polymorphonuclear leukocytes produced pronounced morphological changes in syngeneic tumor cells as evidenced by a substantial reduction in tumor cell numbers and appearance of shrunken cells, even though there was no increase in cell debris. Polymorphonuclear leukocytes exerted a generally similar but quantitatively much diminished effect. These effector cells constantly produced a decrease in the incorporation by tumor cells of DNA precursors such as [(3)H]thymidine and of RNA precursors such as [(3)H]uridine. In this regard, the effector cells were quite refractory to high doses of X-irradiation. Interaction of target cells with activated, nonimmune macrophages yielded low but consistent signs of cytotoxicity, whereas polymorphonuclear leukocytes gave no such effects. Elimination of functional macrophages by silica, an agent specifically toxic for macrophages, resulted in unrestricted tumor cell proliferation despite continued generation of cytotoxicity. Accordingly, cytostatic mechanisms appear to play a predominant role in the elimination of tumor cells by nonimmune phagocytes. Evidence from a variety of experimental approaches suggest that the cytostatic effect is dependent on cell-to-cell contact.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4353819      PMCID: PMC2139416          DOI: 10.1084/jem.138.3.625

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.

Authors:  B Zbar; H T Wepsic; T Borsos; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  ACQUISITION OF HEIGHTENED RESISTANCE AND SUSCEPTIBILITY TO SPONTANEOUS MOUSE MAMMARY CARCINOMAS IN THE ORIGINAL HOST.

Authors:  D W WEISS; L J FAULKIN; K B DEOME
Journal:  Cancer Res       Date:  1964-05       Impact factor: 12.701

3.  The macrophage in allograft immunity. I. Effects of silica as a specific macrophage toxin.

Authors:  N N Pearsall; R S Weiser
Journal:  J Reticuloendothel Soc       Date:  1968-04

4.  Interrelations between different typs of cells. I. A comparative study of the biological properties of a cationic polypeptide from lysosomes of polymorphonuclear leukocytes and other cationic compounds.

Authors:  R Keller; C Mueller-Eckhardt; F H Kayser; H U Keller
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

Review 5.  Experimental studies in tumor imminology.

Authors:  G Klein
Journal:  Fed Proc       Date:  1969 Nov-Dec

Review 6.  Essential relationship between the lymphoid system, immunity, and malignancy.

Authors:  R A Good; J Finstad
Journal:  Natl Cancer Inst Monogr       Date:  1969-07

Review 7.  Tumor antigens.

Authors:  G Klein
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

8.  Role for the macrophage in acquired immunity to phylogenetically unrelated intracellular organisms.

Authors:  J Ruskin; J S Rengton
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

9.  Isolation and cultivation in vitro of macrophages from various sources in the mouse.

Authors:  B Bennett
Journal:  Am J Pathol       Date:  1966-01       Impact factor: 4.307

10.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  44 in total

1.  Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.

Authors:  K Pfizenmaier; H Trostmann; M Röllinghoff; H Wagner
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

2.  Responsiveness of guinea pig alveolar cells.

Authors:  F K Kessler; B J Fisher; D E Bechard; A A Fowler; R A Carchman
Journal:  Lung       Date:  1988       Impact factor: 2.584

Review 3.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

4.  Immunomodulation by Corynebacterium parvum. 1. Variable effects on anti-sheep erythrocyte antibody responses.

Authors:  A Ghaffar; M M Sigel
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

5.  Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors.

Authors:  R Keller
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

Review 6.  Tumor dormancy: a review.

Authors:  E A Alsabti
Journal:  J Cancer Res Clin Oncol       Date:  1979       Impact factor: 4.553

7.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

8.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

9.  In vivo and in vitro macrophage activation by systemic adjuvants.

Authors:  M Bruley-Rosset; I Florentin; G Mathé
Journal:  Agents Actions       Date:  1976-02

10.  Immunological studies on drug-induced allergic hepatitis--hepatocellular injury by macrophage-mediated cytotoxicity.

Authors:  Y Mizoguchi; T Shiba; F Ohnishi; T Monna; S Yamamoto; S Otani; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.